ISLAMABAD, April 12: Drug Information Association of the United States confers a highly prestigious Award upon a Pakistani Canadian.

At its December 2005 meeting, the DIA Board of Directors voted unanimously to confer upon Mohammed Razdar Khan the DIA Outstanding Service Award. It is a highly prestigious award given to a select few each year out of the 30,000 or so DIA members world wide.

Announcing the Award, the president of Drug Information Association Ms Theresa Musser wrote to Mr Khan, “This Award is in recognition of your many sustained and significant contributions to DIA in leadership role. DIA has a reputation among members and nonmembers for offering very high quality meetings, courses and publications. This reputation is due in large measure to the high quality level of your contributions”.

Mr Khan will receive this award during a public ceremony at the DIA Annual Meeting in Philadelphia, PA, June 18-22, which will attract in excess of seven thousand attendees from the pharmaceutical and related industries, academia and regulatory agencies the world over.

Mohammed Razdar Khan immigrated to Canada in 1974 and is currently Director of The Synergex Group Inc, a pharmaceutical consulting organization based in Unionville, Ontario, Canada. His earlier affiliations were with Schering AG in Marketing and Sales, and subsequently with DuPont Pharmaceuticals in Canada, where he directed the Manufacturing, Distribution, Quality Assurance and Compliance operations.

He has also served as a Director of the Pharmaceutical Manufacturers Association of Canada/Plant Operations Section, and more recently on the Board of the Physicians and Nurse Practitioners Alliance of Canada.

He has presented extensively both nationally and internationally on pharmaceutical Quality, Manufacturing and Marketing topics, including at the Drug Information Association and PDA Congresses. He is currently on the DIA’s Advisory Council of North America and is also the Chair of the DIA’s Canadian Programming Steering Committee.